Nikitara Katerina, Cardoso Maria Luis, Vicente Astrid Moura, Batalha Silva Rasga Célia Maria, De Angelis Roberta, Chamoun Morel Zeina, De Nicolo Arcangela, Nomikou Maria, Karamanidou Christina, Kakalou Christine
Hellenic Cancer Federation, Solonos Street 94, 10680 Athens, Greece.
Instituto Nacional de Saúde Doutor Ricardo Jorge, Avenida Padre Cruz, 1649-016 Lisboa, Portugal.
Healthcare (Basel). 2025 Jan 9;13(2):121. doi: 10.3390/healthcare13020121.
Genetic and genomic literacy is pivotal in empowering cancer patients and citizens to navigate the complexities of omics sciences, resolve misconceptions surrounding clinical research and genetic/genomic testing, and make informed decisions about their health. In a fast-evolving scenario where routine testing has become widespread in healthcare, this scoping review sought to pinpoint existing gaps in literacy and understanding among cancer patients and the general public regarding genetics and genomics.
Adhering to the PRISMA framework, the review included 43 studies published between January 2018 and June 2024, which evaluated the understanding of genetics and genomics among cancer patients, caregivers, and citizens.
Although the selected studies had significant heterogeneity in populations and evaluation tools, our findings indicate inadequate literacy levels, with citizens displaying lower proficiency than cancer patients and caregivers. This review highlighted consistent knowledge gaps in understanding the genetic and genomic underpinnings of diseases, encompassing misconceptions about mutation types and inheritance patterns, limited awareness of available genetic testing options, and difficulties in interpreting test results. Ethical and privacy concerns and the psychological impact of genetic testing were also common, highlighting the imperative need for effective communication between healthcare providers and patients.
Given the dynamic nature of genomic science, the review underscores the need for continuously evolving educational programs tailored to diverse populations. Our findings could guide the development of educational resources addressed explicitly to cancer patients, caregivers, and the lay public.
基因和基因组知识素养对于使癌症患者和公众能够应对组学科学的复杂性、消除围绕临床研究以及基因/基因组检测的误解,以及就自身健康做出明智决策至关重要。在医疗保健领域常规检测已广泛普及的快速发展背景下,本范围综述旨在查明癌症患者和公众在基因和基因组知识素养及理解方面现存的差距。
遵循PRISMA框架,该综述纳入了2018年1月至2024年6月期间发表的43项研究,这些研究评估了癌症患者、护理人员和公众对基因和基因组的理解。
尽管所选研究在人群和评估工具方面存在显著异质性,但我们的研究结果表明知识素养水平不足,公众的熟练程度低于癌症患者和护理人员。本综述突出了在理解疾病的基因和基因组基础方面持续存在的知识差距,包括对突变类型和遗传模式的误解、对可用基因检测选项的认识有限以及解读检测结果的困难。伦理和隐私问题以及基因检测的心理影响也很常见,这凸显了医疗服务提供者与患者之间进行有效沟通的迫切需求。
鉴于基因组科学的动态性质,该综述强调需要针对不同人群不断发展教育项目。我们的研究结果可为专门针对癌症患者、护理人员和普通公众的教育资源开发提供指导。